ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL).

B. Selle,C. Bär,S. Hecker,U. Schmidt Rohr,S Viehmann,Klaus-Michael Debatin,Dietrich Reinhardt

ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL).

2002

B. Selle
C. Bär
S. Hecker
U. Schmidt Rohr
S Viehmann
Klaus-Michael Debatin
Dietrich Reinhardt

ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL)

Keywords:

Genetics
Cancer research
Philadelphia Chromosome Positive
ABL
Philadelphia chromosome
Leukemia
Imatinib
Tyrosine-kinase inhibitor
Biology
Chromosomal translocation
Salvage therapy
imatinib mesylate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations